Results: 1-7 |
Results: 7

Authors: Campomenosi, P Monti, P Aprile, A Abbondandolo, A Frebourg, T Gold, B Crook, T Inga, A Resnick, MA Iggo, R Fronza, G
Citation: P. Campomenosi et al., p53 mutants can often transactivate promoters containing a p21 but not Baxor PIG3 responsive elements, ONCOGENE, 20(27), 2001, pp. 3573-3579

Authors: Meinhold-Heerlein, I Ninci, E Ikenberg, H Brandstetter, T Ihling, C Schwenk, I Straub, A Schmitt, B Bettendorf, H Iggo, R Bauknecht, T
Citation: I. Meinhold-heerlein et al., Evaluation of methods to detect p53 mutations in ovarian cancer, ONCOL-BASEL, 60(2), 2001, pp. 176-188

Authors: Brunori, M Malerba, M Kashiwazaki, H Iggo, R
Citation: M. Brunori et al., Replicating adenoviruses that target tumors with constitutive activation of the wnt signaling pathway, J VIROLOGY, 75(6), 2001, pp. 2857-2865

Authors: Gagnebin, J Brunori, M Otter, M Juillerat-Jeanneret, L Monnier, P Iggo, R
Citation: J. Gagnebin et al., A photosensitising adenovirus for photodynamic therapy, GENE THER, 6(10), 1999, pp. 1742-1750

Authors: Saller, E Tom, E Brunori, M Otter, M Estreicher, A Mack, DH Iggo, R
Citation: E. Saller et al., Increased apoptosis induction by 121F mutant p53, EMBO J, 18(16), 1999, pp. 4424-4437

Authors: Yuan, ZQ Wong, N Foulkes, WD Alpert, L Manganaro, F Andreutti-Zaugg, C Iggo, R Anthony, K Hsieh, E Redston, M Pinsky, L Trifiro, M Gordon, PH Lasko, D
Citation: Zq. Yuan et al., A missense mutation in both hMSH2 and APC in an Ashkenazi Jewish HNPCC kindred: implications for clinical screening, J MED GENET, 36(10), 1999, pp. 790-793

Authors: Chappuis, PO Estreicher, A Dieterich, B Bonnefoi, H Otter, M Sappino, AP Iggo, R
Citation: Po. Chappuis et al., Prognostic significance of p53 mutation in breast cancer: Frequent detection of non-missense mutations by yeast functional assay, INT J CANC, 84(6), 1999, pp. 587-593
Risultati: 1-7 |